135 related articles for article (PubMed ID: 17059827)
1. Structures of p38alpha active mutants reveal conformational changes in L16 loop that induce autophosphorylation and activation.
Diskin R; Lebendiker M; Engelberg D; Livnah O
J Mol Biol; 2007 Jan; 365(1):66-76. PubMed ID: 17059827
[TBL] [Abstract][Full Text] [Related]
2. p38alpha is active in vitro and in vivo when monophosphorylated at threonine 180.
Askari N; Beenstock J; Livnah O; Engelberg D
Biochemistry; 2009 Mar; 48(11):2497-504. PubMed ID: 19209848
[TBL] [Abstract][Full Text] [Related]
3. Active mutants of the TCR-mediated p38α alternative activation site show changes in the phosphorylation lip and DEF site formation.
Tzarum N; Diskin R; Engelberg D; Livnah O
J Mol Biol; 2011 Feb; 405(5):1154-69. PubMed ID: 21146537
[TBL] [Abstract][Full Text] [Related]
4. p38α MAP kinase dimers with swapped activation segments and a novel catalytic loop conformation.
Rothweiler U; Åberg E; Johnson KA; Hansen TE; Jørgensen JB; Engh RA
J Mol Biol; 2011 Aug; 411(2):474-85. PubMed ID: 21699901
[TBL] [Abstract][Full Text] [Related]
5. A novel lipid binding site formed by the MAP kinase insert in p38 alpha.
Diskin R; Engelberg D; Livnah O
J Mol Biol; 2008 Jan; 375(1):70-9. PubMed ID: 17999933
[TBL] [Abstract][Full Text] [Related]
6. High-resolution diffracting crystals of intrinsically active p38alpha MAP kinase: a case study for low-throughput approaches.
Diskin R; Engelberg D; Livnah O
Acta Crystallogr D Biol Crystallogr; 2007 Feb; 63(Pt 2):260-5. PubMed ID: 17242519
[TBL] [Abstract][Full Text] [Related]
7. Catalysis and function of the p38 alpha.MK2a signaling complex.
Lukas SM; Kroe RR; Wildeson J; Peet GW; Frego L; Davidson W; Ingraham RH; Pargellis CA; Labadia ME; Werneburg BG
Biochemistry; 2004 Aug; 43(31):9950-60. PubMed ID: 15287722
[TBL] [Abstract][Full Text] [Related]
8. Intrinsically active variants of all human p38 isoforms.
Avitzour M; Diskin R; Raboy B; Askari N; Engelberg D; Livnah O
FEBS J; 2007 Feb; 274(4):963-75. PubMed ID: 17241234
[TBL] [Abstract][Full Text] [Related]
9. Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804.
Xing L; Shieh HS; Selness SR; Devraj RV; Walker JK; Devadas B; Hope HR; Compton RP; Schindler JF; Hirsch JL; Benson AG; Kurumbail RG; Stegeman RA; Williams JM; Broadus RM; Walden Z; Monahan JB
Biochemistry; 2009 Jul; 48(27):6402-11. PubMed ID: 19496616
[TBL] [Abstract][Full Text] [Related]
10. Active mutants of the human p38alpha mitogen-activated protein kinase.
Diskin R; Askari N; Capone R; Engelberg D; Livnah O
J Biol Chem; 2004 Nov; 279(45):47040-9. PubMed ID: 15284239
[TBL] [Abstract][Full Text] [Related]
11. The three-dimensional structure of MAP kinase p38beta: different features of the ATP-binding site in p38beta compared with p38alpha.
Patel SB; Cameron PM; O'Keefe SJ; Frantz-Wattley B; Thompson J; O'Neill EA; Tennis T; Liu L; Becker JW; Scapin G
Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):777-85. PubMed ID: 19622861
[TBL] [Abstract][Full Text] [Related]
12. p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells.
Junttila MR; Ala-Aho R; Jokilehto T; Peltonen J; Kallajoki M; Grenman R; Jaakkola P; Westermarck J; Kähäri VM
Oncogene; 2007 Aug; 26(36):5267-79. PubMed ID: 17334397
[TBL] [Abstract][Full Text] [Related]
13. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
Frembgen-Kesner T; Elcock AH
J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
[TBL] [Abstract][Full Text] [Related]
14. The crystal structure of JNK2 reveals conformational flexibility in the MAP kinase insert and indicates its involvement in the regulation of catalytic activity.
Shaw D; Wang SM; Villaseñor AG; Tsing S; Walter D; Browner MF; Barnett J; Kuglstatter A
J Mol Biol; 2008 Nov; 383(4):885-93. PubMed ID: 18801372
[TBL] [Abstract][Full Text] [Related]
15. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
[TBL] [Abstract][Full Text] [Related]
16. A dimeric kinase assembly underlying autophosphorylation in the p21 activated kinases.
Pirruccello M; Sondermann H; Pelton JG; Pellicena P; Hoelz A; Chernoff J; Wemmer DE; Kuriyan J
J Mol Biol; 2006 Aug; 361(2):312-26. PubMed ID: 16837009
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation.
Perdiguero E; Ruiz-Bonilla V; Gresh L; Hui L; Ballestar E; Sousa-Victor P; Baeza-Raja B; Jardí M; Bosch-Comas A; Esteller M; Caelles C; Serrano AL; Wagner EF; Muñoz-Cánoves P
EMBO J; 2007 Mar; 26(5):1245-56. PubMed ID: 17304211
[TBL] [Abstract][Full Text] [Related]
18. Effect of the distal C162S mutation on the energetics of drug binding to p38alpha MAP kinase.
Todorova NA; Doseeva V; Ramprakash J; Schwarz FP
Arch Biochem Biophys; 2008 Jan; 469(2):232-42. PubMed ID: 17996717
[TBL] [Abstract][Full Text] [Related]
19. The third conformation of p38α MAP kinase observed in phosphorylated p38α and in solution.
Akella R; Min X; Wu Q; Gardner KH; Goldsmith EJ
Structure; 2010 Dec; 18(12):1571-8. PubMed ID: 21134636
[TBL] [Abstract][Full Text] [Related]
20. Mutagenesis of p38alpha MAP kinase establishes key roles of Phe169 in function and structural dynamics and reveals a novel DFG-OUT state.
Bukhtiyarova M; Karpusas M; Northrop K; Namboodiri HV; Springman EB
Biochemistry; 2007 May; 46(19):5687-96. PubMed ID: 17441692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
